Background Polypharmacy is a well-known risk factor for increased morbidity and mortality,[1] especially among elderly people, who are more likely to have comorbid conditions and thus be prescribed... Read More
Case data An 85-year-old previously healthy man was referred for an orthopaedic consultation after he presented with a several-year history of progressive dysphagia along with weight loss of 7.5... Read More
Background Transportation industry statistics from the United States and reports from US researchers indicate an increase in injury and mortality rates for older male motorcyclists.[1-3] Although... Read More
Three new oral anticoagulants (NOACs) are now on the market in Canada for use in patients with nonvalvular atrial fibrillation. The agents are dabigatran, rivaroxaban, and apixaban. Standing in the... Read More
Prostate-specific antigen (PSA) is a highly sensitive serum biomarker that has changed the management of prostate cancer over the past 20 years by allowing clinicians to detect prostate cancer... Read More